EUVIMEDEUVIMED entdecken
Open Access

Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma

Xuekun Fu, Jie Huang, Xinxin Chen, Duoli Xie, Hongzhen Chen, Zhijian Liang, Zhuqian Wang, Yiying Liang, Aiping Lu, Chao Liang

Theranostics · 2025

DOI: 10.7150/thno.99588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Xuekun Fu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Osteosarcoma, Aptamers, Nucleotide, Proto-Oncogene Proteins c-met, Proto-Oncogene Proteins c-mdm2. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaAptamers, NucleotideProto-Oncogene Proteins c-metProto-Oncogene Proteins c-mdm2NucleolinBone NeoplasmsHumansAnimalsCell Line, TumorMiceAntineoplastic AgentsXenograft Model Antitumor AssaysRNA-Binding ProteinsOligodeoxyribonucleotidesPhosphoproteinsMice, NudeMice, Inbred BALB CMolecular Targeted TherapyApoptosisProteolysis

Stichwörter der Autor:innen

AS1411PROTACc-METnucleolinosteosarcoma

Substanzen

Aptamers, NucleotideProto-Oncogene Proteins c-metProto-Oncogene Proteins c-mdm2NucleolinAGRO 100Antineoplastic AgentsRNA-Binding ProteinsOligodeoxyribonucleotidesPhosphoproteinsMDM2 protein, human

Autor:innen und Institutionen

  • Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen 518055, China.
  • Institute of Integrated Bioinfomedicine and Translational Science (IBTS), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR 999077, China.
  • Shenzhen LingGene Biotech Co., Ltd., Shenzhen 518055, China.
  • Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou 510006, China.
  • Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
  • State Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 100850, China.

Zitieren

APA

Fu, X., Huang, J., Chen, X., Xie, D., Chen, H., Liang, Z., Wang, Z., Liang, Y., Lu, A., & Liang, C. (2025). Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma. Theranostics. https://doi.org/10.7150/thno.99588

Vancouver

Fu X, Huang J, Chen X, Xie D, Chen H, Liang Z, et al. Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma. Theranostics. 2025. doi:10.7150/thno.99588

BibTeX
@article{Fu2025,
  author = {Fu, Xuekun and Huang, Jie and Chen, Xinxin and Xie, Duoli and Chen, Hongzhen and Liang, Zhijian and Wang, Zhuqian and Liang, Yiying and Lu, Aiping and Liang, Chao},
  title = {Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.99588}
}
Kostenlos starten →